• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与卵巢癌(瑞典)

Diabetes mellitus and ovarian cancer (Sweden).

作者信息

Weiderpass Elisabete, Ye Weimin, Vainio Harri, Kaaks Rudolf, Adami Hans-Olov

机构信息

International Agency for Research on Cancer, Lyon, France.

出版信息

Cancer Causes Control. 2002 Oct;13(8):759-64. doi: 10.1023/a:1020271000069.

DOI:10.1023/a:1020271000069
PMID:12420955
Abstract

OBJECTIVE

We present results from a large, population-based cohort study in Sweden, where we assessed ovarian cancer risk among patients hospitalized for diabetes mellitus.

METHODS

The cohort was composed of patients identified in the Swedish In-Patient Register as having a hospital discharge diagnosis of diabetes mellitus in 1965-1994. The follow-up was done by linkages with the national cancer register and other population-based registers. Standardized incidence ratios (SIR) were used as a measure of relative risk.

RESULTS

After exclusion of the first year of follow-up (to avoid selection bias), 141,627 women remained in the cohort, contributing 865,746 years of follow-up to the study. The overall SIR for ovarian cancer was 0.97 (95% confidence interval (CI) 0.87-1.08). We found no difference in the risk estimates among women who had been hospitalized for classic complications of diabetes and for those who had not, or according to the duration of follow-up. Women above 40 years of age at first hospitalization presented a SIR of 0.96 (95% CI 0.85-1.07).

CONCLUSIONS

Our study provides evidence of lack of an association between diabetes mellitus and ovarian cancer.

摘要

目的

我们展示了瑞典一项基于人群的大型队列研究的结果,在该研究中我们评估了因糖尿病住院患者的卵巢癌风险。

方法

该队列由在瑞典住院登记册中确定的1965 - 1994年出院诊断为糖尿病的患者组成。通过与国家癌症登记册和其他基于人群的登记册建立联系进行随访。标准化发病率比(SIR)用作相对风险的衡量指标。

结果

在排除随访的第一年(以避免选择偏倚)后,队列中仍有141,627名女性,为该研究贡献了865,746人年的随访数据。卵巢癌的总体标准化发病率比为0.97(95%置信区间(CI)0.87 - 1.08)。我们发现因糖尿病经典并发症住院的女性与未因该并发症住院的女性之间,以及根据随访时间长短划分的女性之间,风险估计没有差异。首次住院时年龄在40岁以上的女性标准化发病率比为0.96(95% CI 0.85 - 1.07)。

结论

我们的研究提供了证据表明糖尿病与卵巢癌之间不存在关联。

相似文献

1
Diabetes mellitus and ovarian cancer (Sweden).糖尿病与卵巢癌(瑞典)
Cancer Causes Control. 2002 Oct;13(8):759-64. doi: 10.1023/a:1020271000069.
2
Reduced risk of prostate cancer among patients with diabetes mellitus.糖尿病患者患前列腺癌的风险降低。
Int J Cancer. 2002 Nov 20;102(3):258-61. doi: 10.1002/ijc.10685.
3
Risk of endometrial and breast cancer in patients with diabetes mellitus.糖尿病患者患子宫内膜癌和乳腺癌的风险。
Int J Cancer. 1997 May 2;71(3):360-3. doi: 10.1002/(sici)1097-0215(19970502)71:3<360::aid-ijc9>3.0.co;2-w.
4
A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus.一项基于大样本人群的队列研究,旨在探讨 2 型糖尿病患者罹患卵巢肿瘤的风险。
Gynecol Oncol. 2014 Sep;134(3):576-80. doi: 10.1016/j.ygyno.2014.07.001. Epub 2014 Jul 9.
5
Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.瑞典的一项全国队列研究:交界性卵巢肿瘤女性的非卵巢癌风险。
BMC Cancer. 2023 Oct 9;23(1):951. doi: 10.1186/s12885-023-11453-6.
6
Incidence of ovarian cancer among alcoholic women: a cohort study in Sweden.瑞典酒精摄入女性中卵巢癌的发病率:一项队列研究
Int J Cancer. 2001 Jan 15;91(2):264-6. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1027>3.3.co;2-b.
7
Excess risk of primary liver cancer in patients with diabetes mellitus.糖尿病患者原发性肝癌的额外风险。
J Natl Cancer Inst. 1996 Oct 16;88(20):1472-7. doi: 10.1093/jnci/88.20.1472.
8
Pancreatitis and pancreatic cancer: a population-based study.胰腺炎与胰腺癌:一项基于人群的研究。
J Natl Cancer Inst. 1994 Apr 20;86(8):625-7. doi: 10.1093/jnci/86.8.625.
9
The role of diabetes mellitus in the aetiology of renal cell cancer.糖尿病在肾细胞癌病因学中的作用。
Diabetologia. 1999 Jan;42(1):107-12. doi: 10.1007/s001250051122.
10
Incidence of cancer among patients with atopic dermatitis.特应性皮炎患者的癌症发病率。
Arch Dermatol. 2005 Sep;141(9):1123-7. doi: 10.1001/archderm.141.9.1123.

引用本文的文献

1
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs.癌症与糖尿病:相互关联的代谢途径及抗糖尿病药物的重新利用作用
Cancer Cell Int. 2021 Sep 17;21(1):499. doi: 10.1186/s12935-021-02202-5.
2
Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case-control studies.糖尿病与卵巢癌风险:队列研究和病例对照研究的系统评价和荟萃分析。
BMJ Open. 2020 Dec 29;10(12):e040137. doi: 10.1136/bmjopen-2020-040137.
3
Impact of diabetes mellitus on epithelial ovarian cancer survival.
糖尿病对卵巢上皮性癌生存的影响。
BMC Cancer. 2018 Dec 12;18(1):1246. doi: 10.1186/s12885-018-5162-3.
4
Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan.2型糖尿病患者的癌症风险:台湾一项基于全国人群队列的10年随访研究
BMC Cancer. 2014 May 29;14:381. doi: 10.1186/1471-2407-14-381.
5
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.糖尿病与癌症(1):评估 2 型糖尿病与癌症发病率之间的时间关系。
Diabetologia. 2012 Jun;55(6):1607-18. doi: 10.1007/s00125-012-2525-1. Epub 2012 Apr 4.
6
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.胰岛素治疗糖尿病患者的癌症发病率和死亡率:一项英国队列研究。
Br J Cancer. 2005 Jun 6;92(11):2070-5. doi: 10.1038/sj.bjc.6602611.